The control of growth and cell proliferation is essential to metazoan development. In general, when cells arrest proliferation they do so in G1; the importance of stable G1 quiescence is dramatized by the consequences of tumor suppressor gene mutations that erode this stability [1, 2] . The characterization of a number of tumor suppressor mutations has demonstrated that the stability of G1 is critically dependent on the signal transduction pathways that regulate the expression of cyclin E in G1 [3] [4] [5] [6] . Studies in mammalian cells have demonstrated that the complex between cyclin A and its catalytic partner, cyclin-dependent kinase 2 (cdk2), is an important S-phase kinase [7, 8] . Here, we use Drosophila as a model to test whether the strict regulation of cyclin E activity can be bypassed by ectopic activation of cyclin A.
Background
The control of growth and cell proliferation is essential to metazoan development. In general, when cells arrest proliferation they do so in G1; the importance of stable G1 quiescence is dramatized by the consequences of tumor suppressor gene mutations that erode this stability [1, 2] . The characterization of a number of tumor suppressor mutations has demonstrated that the stability of G1 is critically dependent on the signal transduction pathways that regulate the expression of cyclin E in G1 [3] [4] [5] [6] . Studies in mammalian cells have demonstrated that the complex between cyclin A and its catalytic partner, cyclin-dependent kinase 2 (cdk2), is an important S-phase kinase [7, 8] . Here, we use Drosophila as a model to test whether the strict regulation of cyclin E activity can be bypassed by ectopic activation of cyclin A.
The first postmitotic quiescent (G1) state in Drosophila embryogenesis occurs in cycle 17 when cyclin E, encoded by the DmcycE gene, becomes limiting for progression to S phase. DmcycE mutant embryos arrest in G1, whereas premature expression of cyclin E results in a precocious advance into S phase [9] [10] [11] . Thus, in Drosophila embryos, as in mammalian cells, activation of cyclin E is a crucial step in the G1/S transition.
Cyclin A-cdk2 activity is detected in mammalian cells at the end of G1 and then rises during S phase [8, 12, 13] . Cyclin A-cdk2 can induce S phase in extracts from G1 cells [12] , and expression of cyclin A in G1 can shorten the G1 period and drive early entry into S phase [14] . Most importantly, the injection of antibodies directed against cyclin A can prevent completion of S phase [7, 8] . In Xenopus, cyclin A2 can promote S phase in interphase extracts depleted of cyclin E [15] . An S phase role for cyclin A in Drosophila was far from evident in earlier work. Endocycle S phases proceed in the absence of cyclin A [16] [17] [18] , and ectopic expression of cyclin A in the embryo induced S phase only in the amnioserosa cells -which are thought to arrest (at least initially) in G2 [19] . However, recent results have suggested that cyclin A in Drosophila can drive G1 cells into S phase. The expression of cyclin A from a heat-shock promoter during eye development induced S phase in the G1 cells of the morphogenetic furrow [20] . Furthermore, in rux mutants, these furrow cells exhibited ectopic expression of cyclin A and 
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Conclusions:
Cyclin A can drive the G1/S transition, but this function is suppressed by three types of control: cyclin A destruction, inhibitory phosphorylation of cdc2, and inhibition by rux. The partly redundant contributions of these three inhibitory mechanisms safeguard the stability of G1 quiescence until the induction of cyclin E. The action of rux during G1 resembles the action of inhibitors of mitotic kinases present during G1 in yeast, although no obvious sequence similarity exists.
premature entry into S phase. Because the rux phenotype was alleviated by reduction of DmcycA function, it seemed likely that the precocious S phase was driven by the ectopic cyclin A, and that rux might then function as a suppressor of DmcycA function [20, 21] .
Cyclin A has an established mitotic function in addition to its role in S phase. In Xenopus, it can induce nuclear envelope breakdown and chromatin condensation and can drive one mitotic cycle [22, 23] . In Drosophila, genetic analysis of DmcycA has shown that cyclin A has mitotic functions that overlap with functions of cyclin B [24] . In vertebrate cells, cyclin A complexes with both cdk2 and cdc2, and it is thought that the S phase role of cyclin A is contributed by the cyclin A-cdk2 complex whereas the G2 role is provided by the cyclin A-cdc2 complex [7, 8, 13, [25] [26] [27] . In Drosophila, however, cyclin A only complexes with cdc2, so that both S and G2 roles are presumed to be carried out by cyclin A-cdc2 (F.S., unpublished observations; [10, 17] ).
Here, we show that the ectopic expression of Drosophila cyclin A can trigger G1/S transitions in embryos even in the absence of cyclin E function, and that three safeguard mechanisms severely limit the efficiency of induction of S phase by ectopic cyclin A: rapid destruction of cyclin A in G1 cells, inhibition of cyclin A-cdc2 by rux, and inhibition of cyclin A-cdc2 by phosphorylation. By bypassing each of these safeguard mechanisms, we show that there is a substantial level of redundancy between them. Genes important for these safeguard mechanisms might behave as tumor suppressor genes in other systems. Additionally, our characterization of rux function suggests that it has widespread roles in regulating cell cycle progression and that it modulates the entry of cyclin A into the nucleus.
Results

Induction of S phase by cyclin A
Lehner et al. [19] expressed cyclin A from a heat-shockinducible promoter, but S phase was not induced in G1 cells. We repeated these experiments using a different heat-shock protocol that produces higher levels of cyclin A but does not decrease viability, alter the S phase program or cause other visible abnormalities in nontransgenic embryos. By varying the length of the heat-shock, we were able to change the amount of cyclin A produced (see Figure 4s ). To examine the effect of the expressed cyclin A on S phase, we labeled embryos for 30 minutes with bromodeoxyuridine (BrdU), beginning 20 minutes after the heat shock. The incorporated BrdU was then detected using indirect immunofluorescence and analyzed on a confocal microscope.
In 7.5-8.5 hour old wild-type (nontransgenic) embryos, BrdU incorporation was seen in the mitotic cells of the nervous system ( Figure 1a ) and in cells of the developing internal organs that undergo endoreduplication cycles (Figure 1b) . Cells of the epidermis are in G1 and do not incorporate BrdU. In the internal tissues, S phases occur in a defined spatial and temporal order [28, 29] ; as shown in Figure 1b , BrdU incorporation could be seen in a few lagging cells of the central midgut, where most cells had completed S phase 17, and in cells throughout the anterior and posterior midgut where S phase 17 has recently started. No incorporation was seen in the salivary gland that had already completed S phase 17 and had not yet started S phase 18.
When cyclin A was expressed from the heat-inducible transgene (HS-DmcycA), the normal pattern of S phase was changed. After a 30 minute heat-shock, S phase was induced throughout the epidermis (Figure 1e ). In the internal tissues, the normal pattern of S phase was eradicated and cells of different tissues that were normally in S phase at different times now incorporated BrdU at the same time (Figure 1f) . Thus, the induction of cyclin A expression triggered premature S phase in epidermal cells and in endocycling tissues. These results are very similar to those obtained after ectopic expression of cyclin E from a heat-shock transgene [10, 29] . Normally it is cyclin E, not cyclin A, that induces endocycle S phases, as a mutation in DmcycE blocks these S phases, while a mutation in DmcycA does not.
The induction of S phase by ectopic cyclin A suggests that cyclin A can replace cyclin E or that cyclin A induces cyclin E. To distinguish between these possibilities, we expressed cyclin A ubiquitously in DmcycE mutant embryos. Within an hour of inducing cyclin A, S phase was induced widely in the internal tissues that would endocycle in wild-type embryos (Figure 2b ), but induction of S phase in the epidermal cells was delayed in the DmcycE mutant embryos compared with control embryos (compare Figure 2b,d,f) . Thus, cyclin A is competent to drive a G1/S transition in the absence of cyclin E, but this induction is modified by DmcycE in some tissues. In contrast to cyclin A or cyclin E, expression of cyclin B from a heat-shock promoter did not induce S phase (data not shown).
To test whether cyclin A is able to induce S phase in a very different context, we expressed cyclin A in G1 cells of the developing Drosophila eye using the sevenless enhancer. Again S phase was induced by the induced expression of cyclin A (data not shown). This is in agreement with a recent report in which heat-shock-induced expression of cyclin A in the eye disk resulted in ectopic S phases [20] . From all these experiments, we conclude that cyclin A can trigger a G1/S transition and induce DNA replication in Drosophila Cyclin A is unstable in G1 Although strong expression of cyclin A induced S phase throughout the embryo, milder heat-shock conditions resulted in a lower level of cyclin A expression (see Figure 4s ), inducing S phase in the internal tissues but not in the epidermis (Figure 1c,d ). To investigate whether cyclin A accumulated in cells of the epidermis under these conditions, we analyzed the expression of cyclin A under different heat-shock conditions. In wild-type embryos, cyclin A protein is detected in the germ-cells that are arrested in G2 (T. Su, personal communication) and in mitotic cells of the nervous system and brain (Figure 3a,b) . After a mild heat shock of 15 minutes, there was an initial accumulation of cyclin A in the epidermis (Figure 3e ) and in internal tissues (Figure 3f ), yet only cells of the internal tissues entered S phase prematurely (Figure 1c,d ). This indicates that the ectopic S phase in the epidermis requires higher levels of cyclin A protein.
We also examined the stability of cyclin A by staining embryos for cyclin A 150 minutes after the heat-shock. In embryos that received a 30 minute heat-shock, almost all cells entered S phase (Figure 1e ,f) and cyclin A was detectable at high levels in cells of the epidermis and in cells of the internal tissues (Figure 3k,l) . In embryos that received a 15 minute heat-shock, which induced S phase in internal tissues and rarely in cells of the epidermis, high levels of cyclin A persisted in the internal tissues, but staining was only visible in a few cells of the epidermis (Figure 3g,h ). These results show that cyclin A is unstable when cells are in G1 and that it is stabilized upon transit to S phase, whether the cells enter S phase of their own accord or are induced to do so by high levels of cyclin A. These data are consistent with observations made by Knoblich et al. [10] . They found that induction of cyclin E, which induced S phase, also allowed accumulation of cyclin A protein without a change in the levels of DmcycA mRNA. This showed that either increased translation or decreased degradation of cyclin A accompanied cyclin E induction [10] .
Instability of mitotic cyclins in G1 has also been described for yeast and mammalian cells [30, 31] . Here, cyclin proteolysis which is necessary for exit from mitosis continues throughout the G1 period (reviewed in [32] ). Degradation is mediated by the ubiquitin-proteasome pathway and is dependent on a small conserved motif in the cyclin sequence, termed the destruction box [33, 34] . Mitotic cyclins lacking the destruction box are resistant to destruction by this mechanism and, when expressed before mitosis, they block exit from mitosis [34] .
To investigate whether the mitotic destruction machinery influences cyclin A activity in G1, we deleted the destruction box from the DmcycA gene (F.S and P.O.F. unpublished observations; [35] ) and expressed the mutant construct (cyclin A s ; Figure 4u ) during cell cycle 17. In this Figure  4s ,t is the result of longer exposure of the cyclin A s blot). Thus, the cyclin A s transgene is not expressed as efficiently as the cyclin A transgene. Titrations of the amount of protein accumulated after different heat shocks showed that ten-fold less cyclin A s was required to induce S phase compared with cyclin A.
Cdc2 activity is suppressed in G1 by inhibitory phosphorylation
Cdk kinase activity is regulated both by phosphorylation and by cyclin binding (reviewed in [36] ). Although inhibitory phosphorylation of cdc2 on the threonine at residue 14 (T14) and the tyrosine at position 15 (Y15) is generally thought to play a major role in controlling the transition from G2 into mitosis, it might also play a role in G1 to restrict the activity of cyclin A-cdc2. As the major target for phosphorylation is the cdk-cyclin complex rather than the free cdk, we would expect the level of inhibitory phosphorylation to depend on the presence of a cyclin partner. In G1 of cycle 17, cdc2 is present in the unphosphorylated form ( Figure 5 ). At this embryonic stage, heat-shock-induced expression of cdc2 led to the accumulation of only the unphosphorylated form (data not shown). Induced expression of both cdc2 and cyclin A led to the accumulation of the phosphoisoforms of cdc2 ( Figure 5 ), indicative of phosphorylation on T14 and Y15 [37] .
To investigate whether inhibitory phosphorylation on cdc2 limits the efficiency of cyclin A induction of S phase, we coexpressed a mutant form of cdc2 that lacks the inhibitory phosphorylation sites, cdc2 T14AY15F (cdc2 AF ). In the absence of induced cyclin A expression, expression of cdc2 AF or cdc2 from heat-shock transgenes had no effect on S-phase induction (data not shown), whereas the coexpression of cdc2 AF with either cyclin A or cyclin A s increased the efficiency of S-phase induction dramatically (Figure 4m-r and data not shown). Coexpression of wild-type cdc2 with cyclin A did not alter significantly the effectiveness of Sphase induction by cyclin A. S phase was not induced by coexpression of cdc2 AF with cyclin B or cyclin B lacking the mitotic destruction box (data not shown). Together, these data show that cyclin A-cdc2 is able to induce S phase, a function of cdc2 not shared by the cyclin B-cdc2 complex. This S-phase function of cdc2 is substantially inhibited in G1 by the presence of kinases that phosphorylate cdc2 on inhibitory phosphorylation sites.
Rux acts an inhibitor of cyclin A in the embryo
Mutations in the rux gene cause premature cell cycle progress in two tissues. In eye discs lacking the function of the rux gene, cells enter S phase precociously, giving rise to a rough eye phenotype [21] . Detailed analysis of this phenotype reveals that rux is required for the acquisition and/or maintenance of G1 in this tissue. In the male gonad, rux function is needed for normal arrest of the cell cycle after meiosis II [38] . Both phenotypes of rux are Cyclin A is competent to drive S phase in the absence of cyclin E. BrdU pulse labelling of control embryos that received no heat-shock (a,c,e) and embryos of the same genotypes after heat-shock treatment (b,d,f). BrdU pulse labelling was performed at the indicated times after heat-shock treatment and on embryos of equivalent age that received no heat shock treatment. (a,b) Embryos carrying two copies of HS-DmcycA. S-phase induction by cyclin A can be observed in DmcycE + embryos in internal tissues (not shown) and the epidermis 1 h after heat-shock. (c-f) Embryos homozygous for DmcycE AR95 carrying two copies of HS-DmcycA. In embryos mutant for DmcycE, S-phase induction by cyclin A can be observed after 1 h in the endoreduplicating tissues (d), but epidermal S-phase induction is not seen until 180 min after S-phase induction (f).
dominantly suppressed by mutations in the DmcycA gene [21, 38] . Loss of rux function also alters cyclin A protein accumulation in these tissues: rux-deficient eye disc cells exhibit ectopic accumulation of cyclin A, and rux-deficient premeiotic germ cells accumulate more cyclin A. An ectopic S phase in the eye disc can also be induced by the expression of cyclin A from a heat-shock transgene [20] or from a transgene in which DmcycA is under the control of the sevenless enhancer (data not shown), raising the possibility that the ectopic S-phase in rux mutants is caused by cyclin A.
The limitation of the rux phenotype to eyes and testis might reflect limited action of this gene, or might be a consequence of special sensitivity of these tissues to loss of rux function. Although rux is a non-lethal gene, strong mutations reduce overall viability. Given the interactions between rux and DmcycA, it seemed likely that, if rux were to have a function in G1 of cycle 17, this function might be exposed by expression of excess cyclin A. BrdU labeling and cyclin A staining did not indicate an abnormal phenotype in rux mutant embryos (data not shown). However, rux mutant embryos were more sensitive to induction of ectopic S phase by cyclin A (Figure 6a-f) . For example, a 10 minute heat-shock of rux mutant embryos carrying a single copy of the HS-DmcycA transgene induced significant S phase in the epidermis (Figure 6d ), whereas a similar heat-shock of a rux + embryos carrying two copies of the transgene failed to induce S phase (Figure 4d ). Thus, rux functions in the early embryo and this function is uncovered when the system is stressed by the ectopic expression of cyclin A.
Ubiquitous induction of rux from a HS-rux transgene had no obvious consequence on the patterns of BrdU incorporation following G1 17. This is consistent with results showing that this S phase is induced by cyclin E and that rux does not inhibit cyclin E function ( [39] ; N.Y. and (Figure 1e ). In contrast to the instability of cyclin A in the epidermis following a 15 min heat-shock (g), the cyclin A that was induced in response to this longer heat-shock persisted in most of the cells of the epidermis (k), as well as persisting in the internal tissues (l). There are a few cells that so not stain for cyclin A after 150 min (see black holes in the staining in panel (k)): these may represent cells that were not induced into S phase by the treatment. The difference between the middle and the bottom series of panels suggests that cyclin A can stabilize itself, and the conditions that lead to stabilization are the same as those that lead to induction of G1 cells into S phase (see Figure 1) .
P.H.O'F., unpublished observations).
In contrast, we observed strong interactions between ectopic rux and ectopic cyclin A: induction of HS-DmcycA produced high levels of cyclin A, whereas coexpression with rux prevented the stable accumulation of cyclin A (Figure 7a ,c and Figure 6o ). The induction of rux also blocked the induction of S phase by HS-DmcycA (data not shown, but see results for cyclin A s below). Although rux might counter cyclin A function by promoting its degradation, it might also inhibit cyclin A activity by a mechanism that is independent of its degradation. We therefore tested the ability of rux to inhibit the activity of the stable form of cyclin A. A comparison of the ability of cyclin A s to induce BrdU incorporation in rux + and rux -mutant embryos demonstrated that the rux mutant embryos were more sensitive to the ectopic expression (compare Figure 4h -j with Figure 6h-j) . Thus, the endogenous rux activity can partially inhibit cyclin A s . Joint overexpression of rux and cyclin A s indicated that rux did not promote the destruction of cyclin A s (in fact, cyclin A s accumulated at higher levels: Figure 6o) . Importantly, the induced rux completely blocked the ability of cyclin A s to induce S phase (Figure 6m,n) . We conclude that rux can inhibit the function of cyclin A in G1, preventing S-phase induction by cyclin A.
Rux causes a change in cyclin A subcellular localization
In wild-type embryos of the cellular blastoderm stage (cell cycle stages 14-16), cyclin A is localized predominantly to the cytoplasm in S and G2. In prophase, it enters the nucleus and is then degraded during mitosis [16] . In G1 cells, cyclin A is unstable and little staining of cytoplasmic cyclin A can be observed (data not shown). Expression of cyclin A from HS-DmcycA during G1 resulted in a G1/S transition and cyclin A accumulation which appeared to be predominantly cytoplasmic (Figure 7a ). In embryos lacking rux function, no change in the localization of endogenous or heat-shock-induced cyclin A protein was observed (data not shown). Heat-shock-induced expression of rux did not alter the general staining pattern of cyclin A in the wild-type embryo (data not shown). However, coexpression of rux and cyclin A prevented the accumulation of cyclin A (Figure 7c ).
The subcellular localization of cyclin A s was strikingly different from that of cyclin A, being distributed homogeneously in the cytoplasm and the nucleus. This suggests that the stabilization of cyclin A allows some accumulation in the nucleus. Upon coexpression with rux, the cyclin A s staining is strongly nuclear. Thus, while overexpression of rux prevents the accumulation of cyclin A, it promotes the localization of cyclin A s to the nucleus.
Discussion
In both vertebrates and flies, the entry into S phase from G1 depends on the activation of E2F and cyclin E [4,6,9,10,40]. However, some studies suggested that cyclin A has some ability to induce G1 cells to enter S phase. Here, we show that heat-shock-induced cyclin A expression can trigger S phase in G1 cells and that this activation of S phase can occur without cyclin E activity. These observations emphasize that the faithful regulation of the G1/S transition by the E2F-cyclin E pathway relies on effective silencing of alternative routes to triggering S phase.
In Drosophila, the introduction of a G1 phase in cell cycle 17 involves the downregulation of cyclin E [10, 29, 41, 42] . Cyclin A is also downregulated in the tissues that enter quiescence [16] , and we show here that ectopic cyclin A activity can drive G1 quiescent cells into S phase. We show that, at the time of cell cycle 17, there are at least three constraints that restrict the ability of cyclin A to drive S phase. These constraints on the activity of cyclin A are likely to be generally important for the stability of G1.
Cyclin A expression can drive S phase even in the absence of DmcycE function
Induction of expression of cyclin A from a transgene under the control of the hsp70 promoter induced S phase in cells that otherwise would have been in G1 of cell cycle 17. Induction of cyclin A in a DmcycE mutant background demonstrated that cyclin A induction is able to bypass the S phase requirement for cyclin E. S phase in the internal tissues followed shortly after induction of cyclin A, while induction of S phase in the epidermis was delayed. The different kinetics may be the result of the cyclin E independent activation of E2F in the internal cells that are scheduled to undergo endocycle S phases [9] . As E2F activity is required for S phase, the delay in the response of the epidermis might reflect inefficient induction of E2F by cyclin A [43] . In any case, it appears that cyclin A induction of S phase can occur in the absence of cyclin E. The DmcycE allele used in this study is a null mutation and maternal cyclin E disappears or is inhibited prior to the time of this experiment ([9-11,41,42], P.H.H.O'F., J. Vidwans and N.Y., unpublished observations). As Drosophila cyclin A interacts only with cdc2, while cyclin E interacts with cdk2, this experiment demonstrates not only that one cyclin can substitute for the other, but also that one kinase can substitute for the other.
As high levels of cyclin A were required to induce S phase in quiescent G1 cells, the high expression might be overwhelming controls that ordinarily act to preclude this action. Analysis of cyclin A levels suggested that rapid degradation of cyclin A during G1 might be one such constraint, while phosphorylation of cdc2 suggested that inhibitory phosphorylation would be another, and the genetic interactions of rux and DmcycA suggested that inhibition by rux might be third. We tested the importance of these by bypassing each of the constraints and examining the effect on the efficiency of cyclin A induction of S phase.
Cyclin A turnover
Experiments in budding yeast first demonstrated that the rapid degradation of cyclins that occurs at mitosis continues during G1 [30] . Recent work has shown that rapid turnover of G2 cyclins also occurs during G1 in mammalian cells [31] . Knoblich et al. [10] had previously demonstrated that cyclin E expression induces cyclin A protein accumulation in cell cycle 17 without an increase in DmcycA mRNA. Here, we show that cyclin A is rapidly degraded in G1 cells and stabilized once cells enter S phase (Figure 3) . Together, the findings in yeasts, flies and vertebrate cells suggest that G1 destruction of G2 cyclins is general.
A transgene encoding a stable form of cyclin A lacking the mitotic destruction box is more effective at inducing S phase than a transgene encoding the normal cyclin A. This increased effectiveness might be because the particular transgene is unusually highly expressed, because the increased stability of the protein ultimately allows it to accumulate to higher levels, or because the changed properties of the product make it a more effective inducer of S phase. Comparisons of protein levels demonstrated that lower levels of cyclin A s are required to induce S phase compared with cyclin A. This increased potency of cyclin A s can be explained if, for example, active cyclin A is a complex that forms slowly. In this case, the complex would have a greater opportunity to form if the cyclin is stable. Its persistence per se might alter the level of posttranslational modifications, complex formation or subcellular distribution, factors that might be important for the S phase function of cyclin A. At present, we cannot discriminate among these possibilities, but the results argue that rapid destruction of cyclin A during G1 limits its activity.
Inhibitory phosphorylation of cdc2 during G1
Cdc2 kinase activity can be regulated by inhibitory phosphorylation on residues T14 and Y15 by Wee-and Mytlike kinases [44, 45] . In G1, cdc2 is normally not phosphorylated because of the lack of cyclins -which must bind to cdc2 for it to be phosphorylated. When we expressed cyclin A in G1, we identified phosphoisoforms of cdc2 that correspond to inhibited, T14-or Y15-phosphorylated forms of cdc2. Thus, inhibitory phosphorylation, which is normally viewed as a regulatory event governing G2, can have a role in G1. Indeed, coexpression of cyclin A and cdc2 AF , a variant lacking the inhibitory phosphorylation sites, enhanced the S-phase-inducing activity of cyclin A. Thus, we conclude that inhibitory phosphorylation restricts activity of cyclin A in G1.
Human cdc25A and cdc25B, which can promote progress of the cell cycle from G1 to S, appear to function as oncogenes [46] This suggests that inhibitory phosphorylation contributes to the stability of G1 in humans. It is not clear, however, whether the cyclin A-associated kinase is a relevant target of inhibitory phosphorylation in mammalian cells as it is in Drosophila.
Rux promotes nuclear localization of cyclin A but inhibits its function in G1 of cycle 17
Studies of rux mutant phenotypes suggested that rux behaves as an inhibitor of DmcycA function in the testis and in the eye [21, 38] . We examined rux mutant embryos to determine whether it has a zygotic function in the embryo. Although we could detect no cell cycle defect in rux mutant embryos, ectopic cyclin A is more effective in inducing S phase in the mutant background. Reciprocally, overexpression of rux completely blocked S phase induction by cyclin A. These results show that rux activity can inhibit cyclin A function and that endogenous rux activity at the time of cycle 17 contributes to the restraints limiting cyclin A activity.
In addition to the inhibition of cyclin A function, we found that the overexpression of rux promoted the degradation of cyclin A and the nuclear localization of cyclin A s .
As the biochemical activity of rux is unknown, any of the observed consequences of rux overexpression might be secondary. However, we found that rux expression blocks the induction of S phase by cyclin A s , which demonstrates that rux has an ability to inhibit cyclin A function that is separate from its ability to promote its degradation. Additionally, we coexpressed cyclin A s and cdc2 AF with or without rux (data not shown); rux was again able to suppress induction of S phase by cyclin A s . As rux inhibition could not be bypassed by either stabilizing cyclin A or blocking inhibitory phosphorylation, we argue that rux has a mode of action that is not mediated by either degradation or inhibitory phosphorylation.
At present, we cannot resolve whether rux has independent activities that promote cyclin A degradation and nuclear localization, or whether these are secondary to other actions of rux. For example, we have shown that cyclin A can promote its own stabilization. As rux inhibits cyclin A activity, it should inhibit the ability of cyclin A to stabilize itself. Such an inhibition of stabilization might account for, or at least contribute to, the apparent enhancement of degradation in response to rux. Alternatively, or additionally, if a rate limiting step in the degradation of cyclin A were to occur in the nucleus, rux-enhanced degradation of cyclin A might be promoted by enhanced nuclear localization.
In Drosophila, cyclin A is cytoplasmic during interphase but enters the nucleus during prophase [16] . In human cells, cyclin A is predominantly nuclear from S phase onwards [47] and colocalizes with replication proteins RP-A and PCNA and with replication origins [48, 49] . Expression of cyclin A in G1 cells of Drosophila embryos results in a predominantly cytoplasmic localization, but the cyclin A s protein is distributed homogeneously throughout the cell. There are at least two possibilities that could account for the difference in the distribution of cyclin A and cyclin A s . If full-length cyclin A is degraded by a destruction system localized to the nucleus, then it would fail to accumulate in this compartment even if it could transit the nuclear membrane. Alternatively, cyclin A s might lack a cytoplasmic retention signal that prevents cyclin A from entering the nucleus. Such a retention sequence might be a cytoplasmic anchor sequence like that described for human cyclin B1 [50] .
The expression of rux changes the subcellular localization of cyclin A: full-length cyclin A is degraded and cyclin A s is present only in the nucleus. In premeiotic spermatocytes, full-length cyclin A is normally cytoplasmic but translocates into the nucleus when the rux gene dose is increased [38] . Additionally, when we induced rux expression in cell cycle 14 or 15 embryos, full-length cyclin A translocated to the nucleus of G2 cells (data not shown). Thus, rux promotes nuclear entry of cyclin A as well as cyclin A s . Our failure to detect nuclear accumulation of cyclin A in G1 cells might then reflect degradation of nuclear cyclin A in G1. Perhaps a key component of cyclin A destruction is localized in the nucleus. In yeast, mutations in a nuclear import receptor block clb2 destruction [51] , suggesting that cyclin destruction might occur in the nucleus. If this were also true for Drosophila, the rux effect on the nuclear translocation of cyclin A would target cyclin A for degradation.
The action of rux
Rux acts as an inhibitor of cyclin A function. On the basis of previous work, it is reasonable to expect that rux, or a rux-dependent factor, might bind to cyclin A-cdc2 and inhibit its activity. Rux is not homologous to known cyclin-dependent kinase inhibitors, however, and we have failed to detect binding of rux to cyclin A or cyclin A-cdc2 in vitro (F.S., unpublished observations). It is possible that rux itself is not the inhibitor, but somehow is required for or promotes the association of a cyclin-dependent kinase inhibitor with cyclin A-cdc2, thus inhibiting its kinase function. Binding of this inhibitor may promote nuclear uptake of the complex, explaining the nuclear localization of cyclin A upon rux expression. Alternatively, rux could promote entry of cyclin A into the nucleus, where the inhibitor is located. Other explanations are possible and more experiments are needed to define the nature of rux inhibition of cyclin A.
At a functional level, rux shares several features with rum1 from Schizosaccharomyces pombe [52] and SIC1 from Saccharomyces cerevisiae [53] . Sic1 protein is present in G1 and inhibits G2 cyclins (Clbs) but not the G1 cyclins (Clns) [54] . The p25 rum1 protein -present in G1 but absent in G2 -acts as an inhibitor of the mitotic cdc13-cdc2 kinase complex. In addition, like rux, it prevents the accumulation of mitotic cyclins in G1 [55] . Formally, rux has activities similar to these yeast inhibitors: all stabilize G1 by inhibiting the activity of G2 cyclins; and all are dispensable, consistent with a role in safeguard mechanisms that ensure the stability of G1 while being dispensable for progress of the cycle. The results presented here suggest that sophisticated and partially redundant safeguard controls make important contributions to the creation of a stable quiescent arrest of the cell cycle. The dissection of events that accompany the introduction of G1 into the embryonic cell cycle should reveal the steps necessary to remodel the cycle for such periods of quiescence.
Materials and methods
Plasmid constructs for germ-line transformation
The construct for the HS-DmcycA s transgene was built by digesting the DmcycA cDNA with EcoRV and EcoRI and ligating it into the vector pSF407, which contains a Xenopus ␤-globin leader as the 5′ untranslated region, resulting in the vector pSF447. This vector was digested with Asp718 and NotI and the DmcycA fragment cloned into pBD403, which contains the hsp70 promoter, resulting in the vector pSF484. For the HS-DmcycB s transgene, a fragment from the DmcycB cDNA was amplified by the polymerase chain reaction using the oligonucleotides SF42 (ATATCCATGGGCATAAGTCGTCC-CATCGCA) and SF43 (GCTCTAGAGCACTATTTCCTCTGGCTCT). The resulting fragment was cut with NcoI and XbaI and exchanged with the cDNA contained in the vector pBtor resulting in pSF254 that contains the coding region for a cyclin B protein lacking the first 46 amino acids. A BstBI-XbaI fragment was excised from this vector and replaced with a BstBI-XbaI fragment from the DmcycB cDNA, resulting in pSF283 from which the insert was moved into a Bluescript based vector thereby creating pSF463. Then the insert was excised with Asp718/NotI and cloned into pBD403, resulting finally in the vector used for germ-line transformation, pSF483.
Fly stocks
Control embryos are of the genotype y w 67 , the parental strain used for germ-line transformation. The fly-stocks with the transgenes HSDmcycA, HS-DmcycB and HS-cdc2, allowing the expression of DmcycA cDNA, DmcycB cDNA and Dmcdc2 cDNA under the control of a heat-shock promoter, have been described [24, 56] The fly stock carrying the HS-cdc2 AF transgene was made by P. Leopold, L. Connely and P.H.H.O'F. (unpublished). For the HS-DmcycA s and HS-DmcycB s fly stocks, germ-line transformation was performed by standard Pelement transformation into y w 67 host strains using the plasmids pSF484 (for HS-DmcycA s ) and pSF483 (for HS-DmcycB s ). The HSrux fly stock was kindly provided by B. Thomas (NCI, Bethesda).
Egg collection, heat-shock procedure and BrdU labeling
Embryos were collected on grape-juice agar plates for 1 h and aged for 7 h. Heat-shocks were performed by floating the agar plates for 30 min. directly on the surface of a water bath placed in a 37°C incubator. After heat-shock, the plates were returned to room temperatures. After various recovery times from the heat-shock (see text), the embryos were washed into a basket, dechorionated with 50% bleach, washed extensively with water, dehydrated for 30 sec with isopropanol, permeabilized with octane for 180 sec and placed into Schneider's Medium containing 1 mg/ml BrdU for 20 min. Immediately after the BrdU pulse, the embryos were devitellinized and fixed in 1:1 mixture of methanol and heptane, washed twice with methanol and then fixed for 15 min. with 8% formaldehyde. To detect incorporated BrdU, the embryos were hydrolyzed in 2 N HCl for 40 min., neutralized in 0.1 M Na 2 B 4 O 7 and washed in PBS containing 0.2 % Tween 20 several times. Incorporated BrdU was observed by immunofluorescence. To block unspecified binding, embryos were incubated in 5% normal goat serum (Jackson Labs) before adding mouse monoclonal anti-BrdU (Beckton Dickinson) primary antibody. For conventional microscopy studies, rhodamine-conjugated goat anti-mouse (Jackson Labs) secondary antibodies were used to visualize BrdU incorporation. For confocal microscopy studies, a FITC-conjugated goat anti-mouse primary antibody was used, the embryos treated with RNAse A (1 mg/ml) for one hour and DNA stained with 1 g/ml propidium-iodide.
Cyclin A antibodies
Cyclin A protein was expressed and isolated from bacteria. The purified protein was used to immunize rabbits (Caucalito) and polyclonal serum was affinity purified against the bacterially expressed cyclin A protein coupled to cyanogen-bromide activated Sepharose 4B.
Immunoblotting
Heat-shocked embryos were recovered at room temperature for the times indicated, dechorionated, and solubilized in SDS-gel sample buffer. After SDS-PAGE, gels were immunoblotted onto PVDF-membrane (Millipore), blocked with 5% milk in PBS containing 0.2% Tween 20 and incubated with affinity purified cyclin A antibody. After an incubation with horseradish peroxidase labeled secondary antibody (Amersham), the blots were developed using the ECL system (Amersham) and Hyperfilm (Amersham) to detect the signal.
Immunofluorescence detection of cyclin A
Embryos were fixed in 4% formaldehyde for 10 min, devitellinized and blocked for 1 h with 5% normal goat serum in PBS with 0.2% Tween 20 (PBT). Affinity purified cyclin A antibody applied over night in PBT, embryos washed 3 times with PBT and then incubated for 2 h with preabsorbed FITC labeled goat-anti-rabbit antibodies (Jackson Laboratory) in PBT containing 1 mg/ml RNAse A. Embryos were washed three times with PBT and embedded in Vectashield mounting medium (Vector Laboratories).
